A large cohort of consecutive patients confirmed frequent HER2 positivity in gastric carcinomas with advanced stages. (Q53347431)

13 May 2018

title

A large cohort of consecutive patients confirmed frequent HER2 positivity in gastric carcinomas with advanced stages. (English)

1 reference

13 May 2018

Chang Ohk Sung

4

0 references

author name string

Junhun Cho

1

1 reference

13 May 2018

Jiyun Jeong

2

1 reference

13 May 2018

Jiyoun Sung

3

1 reference

13 May 2018

Kyoung-Mee Kim

5

1 reference

13 May 2018

Cheol Keun Park

6

1 reference

13 May 2018

Min Gew Choi

7

1 reference

13 May 2018

Tae Sung Sohn

8

1 reference

13 May 2018

Jae Moon Bae

9

1 reference

13 May 2018

Sung Kim

10

1 reference

13 May 2018

publication date

30 December 2012

1 reference

13 May 2018

Annals of Surgical Oncology

published in

1 reference

13 May 2018

volume

20 Suppl 3

1 reference

13 May 2018

page(s)

S477-84

1 reference

13 May 2018

Gastric cancer epidemiology and risk factors

cites work

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2818-0

Global patterns of cancer incidence and mortality rates and trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2818-0

Gastric Cancer Working Group Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2818-0

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2818-0

HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2818-0

HER-2/neu amplification is an independent prognostic factor in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2818-0

Correlation of c-erbB-2 protein expression and lymph node status in early gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2818-0

Assessment of a HER2 scoring system for gastric cancer: results from a validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2818-0

Prognostic significance of HER2/neu expression in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2818-0

Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2818-0

Clinicopathologic characteristics of patients with stage III/IV (M(0)) advanced gastric cancer, according to HER2 status assessed by immunohistochemistry and fluorescence in situ hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2818-0

Clinicopathologic significance of HER-2/neu protein expression and gene amplification in gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2818-0

Low frequency of HER2 amplification and overexpression in early onset gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2818-0

A study of HER2 gene amplification and protein expression in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2818-0

Overexpression of HER2/neu in solid tumours: an immunohistochemical survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2818-0

c-erb B-2 expression is associated with tumor location and venous invasion and influences survival of patients with gastric carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2818-0

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2818-0

Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2818-0

Overexpression of Grb2/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2818-0

Comparison of four immunohistochemical tests and FISH for measuring HER2 expression in gastric carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2818-0

HER2 testing in gastric cancer: a practical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2818-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2818-0

10.1245/S10434-012-2818-0

21 January 2018

Identifiers

DOI

1 reference

13 May 2018

Dimensions Publication ID

1026609323

0 references

1 reference

13 May 2018